Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Tylosin is a macrolide-class broad spectrum antibiotic that's used in veterinary medicine to treat felines, canines and livestock. However, the drug is only used as an antibiotic in the treatment of infections in livestock. In cats, dogs, and other smaller animals, it is used predominantly for its anti-inflammatory properties to treat inflammatory conditions in the bowel. As such, it is commonly prescribed to pets that are suffering from diarrhea.
Scope of the Report:
This report focuses on the Tylosin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Tylosin is a macrolide antibiotic commonly used in food animals. It is a macrolide antibiotic, mainly active against Gram-positive bacteria and mycoplasmas. It is also active against some Gram-negative bacteria, spriochetes, some rickettsia and chlamydia. According to the different materials, tylosin is divided into tylosin tartrate, tylosin phosphate, tylosin base. Tylosin tartrate is mainly cure or prevented mycoplasma diseases and respiratory diseases. And it is the most widely used type which takes up about 68.22% of the global in 2015.
There are companies adding new capacities and aims at the cost and quality leadership which shall improve profitability. As the same time, companies are focusing on technological innovation, equipment upgrades, and process improvements, to reduce costs and improve quality. The competition in tylosin market will become more intense.
The worldwide market for Tylosin is expected to grow at a CAGR of roughly 0.2% over the next five years, will reach 390 million US$ in 2023, from 390 million US$ in 2017, according to a new WMR study.
Market Segment by Manufacturers, this report covers
Qilu Pharmaceutical (Inner Mongolia)
Top Pharm Chemical Group
Lukang Shelile Pharmaceutical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Market Segment by Applications, can be divided into
Animal Feed Additives
There are 15 Chapters to deeply display the global Tylosin market.
Chapter 1, to describe Tylosin Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Tylosin, with sales, revenue, and price of Tylosin, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Tylosin, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Tylosin market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Tylosin sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source